KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biogen (BIIB) Amortization - Intangibles (2016 - 2026)

Biogen has reported Amortization - Intangibles over the past 18 years, most recently at $136.5 million for Q1 2026.

  • For Q1 2026, Amortization - Intangibles rose 22.09% year-over-year to $136.5 million; the TTM value through Mar 2026 reached $539.7 million, up 12.39%, while the annual FY2025 figure was $515.0 million, 15.29% up from the prior year.
  • Amortization - Intangibles for Q1 2026 was $136.5 million at Biogen, roughly flat from $136.6 million in the prior quarter.
  • Over five years, Amortization - Intangibles peaked at $175.0 million in Q4 2022 and troughed at $50.2 million in Q1 2023.
  • A 5-year average of $100.3 million and a median of $86.9 million in 2024 define the central range for Amortization - Intangibles.
  • On a YoY basis, Amortization - Intangibles climbed as much as 156.98% in 2022 and fell as far as 88.83% in 2022.
  • Year by year, Amortization - Intangibles stood at $175.0 million in 2022, then plummeted by 56.23% to $76.6 million in 2023, then surged by 97.39% to $151.2 million in 2024, then decreased by 9.66% to $136.6 million in 2025, then dropped by 0.07% to $136.5 million in 2026.
  • Business Quant data shows Amortization - Intangibles for BIIB at $136.5 million in Q1 2026, $136.6 million in Q4 2025, and $135.7 million in Q3 2025.